RxDoctor Payments Data

Michael Miller, MD

Adult Reconstructive Orthopaedic Surgery · Tucson, AZNPI 1114005253

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,304,273 of the $2,313,763 with a category attached, or 99.6%. Zimmer Biomet accounts for 100.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $584,149 and has fallen 99.9% since, to $349 in 2025. Among adult reconstructive orthopaedic surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,313,763in general payments, 2019–2025

Across 80 payments — averaging $28,922 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$2.3M
  • Smith+Nephew$492
  • Nextstep Arthropedix, LLC$218
  • Pacira Pharmaceuticals Incorporated$54
  • Stryker$50
  • Total Joint Orthopedics, Inc.$44
  • plus $137 from 7 others
$14,727in research payments, 2019–2025

Across 13 payments — averaging $1132.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$15K

What the payments were for

  • Royalty or licence$2,304,273100%
  • Consulting fees$6,8750%
  • Travel & lodging$1,0850%
  • Food & beverage$1,5300%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,313,763 in reported general payments places this provider in the 95th percentile of 43 adult reconstructive orthopaedic surgery providers in Arizona.

See all adult reconstructive orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$389,894
Medicare patients
514
Services billed
4,075

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib131$7,342
Doxycycline Hyclate15$669
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$647
Oxycodone Hcl87$471
Cephalexin26$305
Gabapentin21$292
Tramadol Hcl76$283
Meloxicam51$232
Clindamycin Hcl16$197
Amoxicillin102$169
Ondansetron OdtOndansetron13$134
Zolpidem Tartrate12$89
Methylprednisolone15$84

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →